| Trading Companies & Distributors Industry | Industrials Sector | Dawnte Bailey CEO | OTC PINK Exchange | 90042T206 CUSIP |
| US Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
HealthSpan Medical Systems, Inc. represents a pioneering venture in the healthcare sector, focusing on the development of medical solutions that incorporate marijuana into traditional medical practices. Having been established in 2018, the company situates its headquarters in Ft. Lauderdale, Florida, signaling its emergence within a legal and regulatory environment conducive to researching and deploying marijuana-based medical therapies. Targeting healthcare practitioners, HealthSpan Medical Systems, Inc. aims to integrate cannabinoid-based treatments into the broader spectrum of medical care, offering innovative intravenous (IV) therapy solutions to a range of medical conditions and patient needs.
The core product offering of HealthSpan Medical Systems, Inc. revolves around its marijuana-based IV infusion blends, designed specifically for medical use by healthcare practitioners. These specialized infusion blends cater to the therapeutic needs of patients, leveraging the medicinal properties of cannabinoids. The formulation of these intravenous therapies is rooted in the potential health benefits of marijuana, such as pain relief, anti-inflammatory properties, and neurological benefits, among others. Aimed at integrating seamlessly into various treatment protocols, these IV blends represent a novel approach in the realm of medical treatments, promising to deliver an alternative avenue for patient care and symptom management.